SBIR/STTR Research Award
NEUROTROPIC GECTOSOMES AS A CNS GENE DELIVERY SYSTEM FOR AD/ADRD THERAPY DEVELOPMENT
Award amount
$475,152Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Vesicle Therapeutics Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KALZFKXVQTA6
- Solicitation number
- PHS-2022-1
- Topic code
- 4
Research abstract
To develop a safe and effective platform technology for delivering gene therapy solutions to the central nervous system.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Targeting STAT3 with Novel Thiomorpholino Antisense Oligonucleotides for Cancer Therapy
- Targeting GPR146 for the Treatment of Homozygous Familial Hypercholesterolemia
- Development of a Gectosome Therapy for Cardiovascular Diseases
Research funding history
4 SBIR/STTR records share this UEI (2022–2025). Reported award amounts total $1,619,820. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services